H.J. Lenz
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
Papers in
- Oncology 17
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 3
- HER2/EGFR in Cancer Research 2
- Peptidase Inhibition and Analysis 2
-
- Genetic factors in colorectal cancer 5
- Co-authors
- Dong‐Ho Park (1 shared paper)Ka Yeung Mark Wong (1 shared paper)Arteid Memaj (1 shared paper)Ray McDermott (1 shared paper)Michael B. Sawyer (1 shared paper)Scott Kopetz (1 shared paper)Eric Van Cutsem (1 shared paper)Thierry André (1 shared paper)
- Journals
- Annals of Oncology (7 papers)Journal of Clinical Oncology (5 papers)The Pharmacogenomics Journal (3 papers)Seminars in Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesFranceBelgium
In The Last Decade
H.J. Lenz
24 papers receiving 552 citations
H.J. Lenz's Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 324
- Cancer Research 80
- Pathology and Forensic Medicine 88
- Hepatology 25
- Biotechnology 29
Countries citing papers authored by H.J. Lenz
This map shows the geographic impact of H.J. Lenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.J. Lenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.J. Lenz more than expected).
Fields of papers citing papers by H.J. Lenz
This network shows the impact of papers produced by H.J. Lenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.J. Lenz. The network helps show where H.J. Lenz may publish in the future.
Co-authors
The 25 scholars most cited alongside H.J. Lenz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142 Hit paper breakdown → | 2022 | 167 |
| 2 | 2003 | 145 | |
| 3 | 2006 | 43 | |
| 4 | Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress. | 1995 | 42 |
| 5 | 2012 | 39 | |
| 6 | 2013 | 30 | |
| 7 | Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity. | 1998 | 29 |
| 8 | 2003 | 25 | |
| 9 | 2003 | 14 | |
| 10 | 2012 | 5 | |
| 11 | 2021 | 4 | |
| 12 | 2011 | 3 | |
| 13 | 2013 | 3 | |
| 14 | 2013 | 3 | |
| 15 | 2024 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2012 | 2 | |
| 18 | 2008 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2005 | 1 |
About H.J. Lenz
H.J. Lenz is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 25 papers that have together received 566 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Genomics and Diagnostics (3 papers), Cancer-related Molecular Pathways (3 papers), HER2/EGFR in Cancer Research (2 papers), Estrogen and related hormone effects (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (324 citations), Cancer Research (80 citations), Pathology and Forensic Medicine (88 citations), Hepatology (25 citations) and Biotechnology (29 citations). H.J. Lenz has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Dong‐Ho Park, Ka Yeung Mark Wong, Arteid Memaj, Ray McDermott, Michael B. Sawyer, Scott Kopetz, Eric Van Cutsem, Thierry André, Massimo Aglietta and Andrew Hill. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Pharmacogenomics Journal, Seminars in Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.